These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22459300)

  • 1. Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.
    Tomova GS; Nimbal V; Horwich TB
    Am J Cardiol; 2012 Jun; 109(12):1767-73. PubMed ID: 22459300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study.
    Eskesen K; Jensen MT; Galatius S; Vestergaard H; Hildebrandt P; Marott JL; Jensen JS
    J Intern Med; 2013 Jan; 273(1):94-101. PubMed ID: 23009556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
    Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
    Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
    Gerstein HC; Swedberg K; Carlsson J; McMurray JJ; Michelson EL; Olofsson B; Pfeffer MA; Yusuf S;
    Arch Intern Med; 2008 Aug; 168(15):1699-704. PubMed ID: 18695086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
    Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of measuring glycosylated hemoglobin in patients with myocardial infarction and known diabetes mellitus.
    Stolker JM; Sun D; Conaway DG; Jones PG; Masoudi FA; Peterson PN; Krumholz HM; Kosiborod M; Spertus JA
    Am J Cardiol; 2010 Apr; 105(8):1090-4. PubMed ID: 20381658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
    Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
    Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation.
    Huang H; Liu J; Li Q; Qiao L; Chen S; Kang Y; Lu X; Zhou Y; He Y; Chen J; Tan N; Liu J; Liu Y
    Atherosclerosis; 2024 Jul; 394():117306. PubMed ID: 37821270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
    Pazin-Filho A; Kottgen A; Bertoni AG; Russell SD; Selvin E; Rosamond WD; Coresh J
    Diabetologia; 2008 Dec; 51(12):2197-204. PubMed ID: 18828004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus.
    Sluik D; Boeing H; Montonen J; Kaaks R; Lukanova A; Sandbaek A; Overvad K; Arriola L; Ardanaz E; Saieva C; Grioni S; Tumino R; Sacerdote C; Mattiello A; Spijkerman AM; van der A DL; Beulens JW; van Dieren S; Nilsson PM; Groop LC; Franks PW; Rolandsson O; Bueno-de-Mesquita B; Nöthlings U
    PLoS One; 2012; 7(6):e38877. PubMed ID: 22719972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
    Aguilar D; Bozkurt B; Ramasubbu K; Deswal A
    J Am Coll Cardiol; 2009 Jul; 54(5):422-8. PubMed ID: 19628117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study.
    Kong MG; Jang SY; Jang J; Cho HJ; Lee S; Lee SE; Kim KH; Yoo BS; Kang SM; Baek SH; Choi DJ; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Lim S; Park SK; Lee HY
    Cardiovasc Diabetol; 2020 May; 19(1):49. PubMed ID: 32359358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
    Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY
    Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.
    Selvin E; Coresh J; Golden SH; Brancati FL; Folsom AR; Steffes MW
    Arch Intern Med; 2005 Sep; 165(16):1910-6. PubMed ID: 16157837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).
    Khaw KT; Wareham N; Luben R; Bingham S; Oakes S; Welch A; Day N
    BMJ; 2001 Jan; 322(7277):15-8. PubMed ID: 11141143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction.
    Pastormerlo LE; Mammini C; Giannoni A; Valleggi A; Prontera C; Gabutti A; Poletti R; Padeletti L; Emdin M; Passino C
    J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):423-30. PubMed ID: 25083720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control and cardiovascular events in diabetic hemodialysis patients.
    Drechsler C; Krane V; Ritz E; März W; Wanner C
    Circulation; 2009 Dec; 120(24):2421-8. PubMed ID: 19948978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
    Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
    Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.